This is a summary of the European public assessment report (EPAR) for Memantine Accord. It explains how the Agency assessed the medicine to recommend its authorisation in the EU and its conditions of use. It is not intended to provide practical advice on how to use Memantine Accord. For practical information about using Memantine Accord, patients should read the package leaflet or contact their doctor or pharmacist.
Therapeutic Indication
Treatment of patients with moderate to severe Alzheimer’s disease.
Therapeutic Area (MeSH)
ATC Code
N06DX01
ATC Item
N/A
Pharmacotherapeutic Group
Other anti-dementia drugs
Active Substance (Summary)
INN / Common Names
EMA Name
Memantine Accord
Medicine Name
Memantine Accord
Aliases
N/ANo risk management plan link.
